130 related articles for article (PubMed ID: 30343993)
1. Mobile phone apps for the prediction of prostate cancer: External validation of the Coral and Rotterdam apps.
De Nunzio C; Lombardo R; Tema G; Cancrini F; Russo GI; Chacon R; Garcia-Cruz E; Ribal MJ; Morgia G; Alcaraz A; Tubaro A
Eur J Surg Oncol; 2019 Mar; 45(3):471-476. PubMed ID: 30343993
[TBL] [Abstract][Full Text] [Related]
2. Prostate Cancer Risk Calculator Apps in a Taiwanese Population Cohort: Validation Study.
Chen IA; Chu CH; Lin JT; Tsai JY; Yu CC; Sridhar AN; Sooriakumaran P; Loureiro RCV; Chand M
J Med Internet Res; 2020 Dec; 22(12):e16322. PubMed ID: 33337340
[TBL] [Abstract][Full Text] [Related]
3. Comparing a new risk prediction model with prostate cancer risk calculator apps in a Taiwanese population.
Chen IHA; Chu CH; Lin JT; Tsai J-; Yu CC; Sridhar AN; Chand M; Sooriakumaran P
World J Urol; 2021 Mar; 39(3):797-802. PubMed ID: 32436074
[TBL] [Abstract][Full Text] [Related]
4. Rotterdam mobile phone app including MRI data for the prediction of prostate cancer: A multicenter external validation.
De Nunzio C; Lombardo R; Baldassarri V; Cindolo L; Bertolo R; Minervini A; Sessa F; Muto G; Bove P; Vittori M; Bozzini G; Castellan P; Mugavero F; Falsaperla M; Schips L; Celia A; Bada M; Porreca A; Pastore A; Al Salhi Y; Giampaoli M; Novella G; Rizzetto R; Trabacchin N; Mantica G; Pini G; Remmers S; Antonelli A; Tubaro A
Eur J Surg Oncol; 2021 Oct; 47(10):2640-2645. PubMed ID: 33965292
[TBL] [Abstract][Full Text] [Related]
5. 'Prostate Cancer Risk Calculator' mobile applications (Apps): a systematic review and scoring using the validated user version of the Mobile Application Rating Scale (uMARS).
Adam A; Hellig JC; Perera M; Bolton D; Lawrentschuk N
World J Urol; 2018 Apr; 36(4):565-573. PubMed ID: 29222595
[TBL] [Abstract][Full Text] [Related]
6. Rotterdam Prostate Cancer Risk Calculator: Development and Usability Testing of the Mobile Phone App.
Pereira-Azevedo N; Osório L; Fraga A; Roobol MJ
JMIR Cancer; 2017 Jan; 3(1):e1. PubMed ID: 28410180
[TBL] [Abstract][Full Text] [Related]
7. Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators.
Roobol MJ; van Vugt HA; Loeb S; Zhu X; Bul M; Bangma CH; van Leenders AG; Steyerberg EW; Schröder FH
Eur Urol; 2012 Mar; 61(3):577-83. PubMed ID: 22104592
[TBL] [Abstract][Full Text] [Related]
8. Do prostate cancer-related mobile phone apps have a role in contemporary prostate cancer management? A systematic review by EAU young academic urologists (YAU) urotechnology group.
Jamnadass E; Rai BP; Veneziano D; Tokas T; Rivas JG; Cacciamani G; Somani B
World J Urol; 2020 Oct; 38(10):2411-2431. PubMed ID: 32322996
[TBL] [Abstract][Full Text] [Related]
9. Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth.
Roobol MJ; Verbeek JFM; van der Kwast T; Kümmerlin IP; Kweldam CF; van Leenders GJLH
Eur Urol; 2017 Jul; 72(1):45-51. PubMed ID: 28162815
[TBL] [Abstract][Full Text] [Related]
10. Systematic Review of Commercially Available Mobile Phone Applications for Prostate Cancer Education.
Owens OL; Beer JM; Reyes LI; Thomas TL
Am J Mens Health; 2019; 13(1):1557988318816912. PubMed ID: 30526243
[TBL] [Abstract][Full Text] [Related]
11. Digital rectal examination and the diagnosis of prostate cancer--a study based on 8 years and three screenings within the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam.
Gosselaar C; Roobol MJ; van den Bergh RC; Wolters T; Schröder FH
Eur Urol; 2009 Jan; 55(1):139-46. PubMed ID: 18406045
[TBL] [Abstract][Full Text] [Related]
12. Prospective validation of a risk calculator which calculates the probability of a positive prostate biopsy in a contemporary clinical cohort.
van Vugt HA; Kranse R; Steyerberg EW; van der Poel HG; Busstra M; Kil P; Oomens EH; de Jong IJ; Bangma CH; Roobol MJ
Eur J Cancer; 2012 Aug; 48(12):1809-15. PubMed ID: 22406050
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer detection rate at repeat saturation biopsy: PCPT risk calculator versus PCA3 score versus case-finding protocol.
Pepe P; Aragona F
Can J Urol; 2013 Feb; 20(1):6620-4. PubMed ID: 23433132
[TBL] [Abstract][Full Text] [Related]
14. Prediction of Prostate Cancer: External Validation of the ERSPC Risk Calculator in a Contemporary Dutch Clinical Cohort.
Gayet M; Mannaerts CK; Nieboer D; Beerlage HP; Wijkstra H; Mulders PFA; Roobol MJ
Eur Urol Focus; 2018 Mar; 4(2):228-234. PubMed ID: 28753781
[TBL] [Abstract][Full Text] [Related]
15. A novel urinary long non-coding RNA transcript improves diagnostic accuracy in patients undergoing prostate biopsy.
Zhang W; Ren SC; Shi XL; Liu YW; Zhu YS; Jing TL; Wang FB; Chen R; Xu CL; Wang HQ; Wang HF; Wang Y; Liu B; Li YM; Fang ZY; Guo F; Lu X; Shen D; Gao X; Hou JG; Sun YH
Prostate; 2015 May; 75(6):653-61. PubMed ID: 25597901
[TBL] [Abstract][Full Text] [Related]
16. Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.
Van Neste L; Hendriks RJ; Dijkstra S; Trooskens G; Cornel EB; Jannink SA; de Jong H; Hessels D; Smit FP; Melchers WJ; Leyten GH; de Reijke TM; Vergunst H; Kil P; Knipscheer BC; Hulsbergen-van de Kaa CA; Mulders PF; van Oort IM; Van Criekinge W; Schalken JA
Eur Urol; 2016 Nov; 70(5):740-748. PubMed ID: 27108162
[TBL] [Abstract][Full Text] [Related]
17. The role of the digital rectal examination in subsequent screening visits in the European randomized study of screening for prostate cancer (ERSPC), Rotterdam.
Gosselaar C; Roobol MJ; Roemeling S; Schröder FH
Eur Urol; 2008 Sep; 54(3):581-8. PubMed ID: 18423977
[TBL] [Abstract][Full Text] [Related]
18. Prostate health index (PHI) and prostate-specific antigen (PSA) predictive models for prostate cancer in the Chinese population and the role of digital rectal examination-estimated prostate volume.
Chiu PK; Roobol MJ; Teoh JY; Lee WM; Yip SY; Hou SM; Bangma CH; Ng CF
Int Urol Nephrol; 2016 Oct; 48(10):1631-7. PubMed ID: 27349564
[TBL] [Abstract][Full Text] [Related]
19. A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam.
Roobol MJ; Zhu X; Schröder FH; van Leenders GJ; van Schaik RH; Bangma CH; Steyerberg EW
Eur Urol; 2013 Apr; 63(4):627-33. PubMed ID: 22841675
[TBL] [Abstract][Full Text] [Related]
20. Mobile Phone Apps for Quality of Life and Well-Being Assessment in Breast and Prostate Cancer Patients: Systematic Review.
Rincon E; Monteiro-Guerra F; Rivera-Romero O; Dorronzoro-Zubiete E; Sanchez-Bocanegra CL; Gabarron E
JMIR Mhealth Uhealth; 2017 Dec; 5(12):e187. PubMed ID: 29203459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
